Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab + TP-CCRT in Loco-regional ESCC
NCT01034189Phase 2Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Oct 2008
- Primary completion
- Dec 2010
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
cetuximab
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT01034189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01034189.